SCHEMBL29704124

SCHEMBL29704124

Cc1ccc(-c2cn(C)cn2)cc1S(N)(=O)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 9/20 0.51
▸ CA1 P00915 7/20 0.51
▸ CA9 Q16790 6/20 0.51
▸ CA12 O43570 5/20 0.51
▸ BRD4 O60885 1/20 0.48
▸ BRD2 P25440 1/20 0.48
▸ BRD3 Q15059 1/20 0.48
▸ CA7 P43166 3/20 0.47
▸ MAOB P27338 1/20 0.47
▸ CA4 P22748 2/20 0.46
▸ CYP2E1 P05181 1/20 0.44
▸ CYP2A6 P11509 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2B6 P20813 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ LRRK2 Q5S007 1/20 0.41
▸ GPR174 Q9BXC1 2/20 0.41
▸ TTK P33981 1/20 0.40
▸ MAPK8 P45983 1/20 0.40
▸ ENPP3 O14638 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20092109 0.77 SYK (0.48) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL10689734 0.75 MAOB (0.55) CA2CA1CA9CA12BRD4
SCHEMBL28732947 0.75 BRD4 (0.53) CA2CA1CA9CA12BRD4
SCHEMBL29602351 0.75 BRD4 (0.53) CA2CA1CA9CA12BRD4
SCHEMBL31331822 0.73 PIK3CD (0.43) CA2CA1CA9CA12BRD4
SCHEMBL28478169 0.73 CYP2E1 (0.46) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL22652215 0.73 ALDH1A1 (0.53) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL22635577 0.73 CYP2C9 (0.43) CA2CA1CA9CA12BRD4
SCHEMBL22718340 0.72 LRRK2 (0.40) CA2CA1CA9CA12CYP2E1
SCHEMBL29704120 0.72 LRRK2 (0.40) CA2CA1CA9CA12CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4281073-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2023-11-29 — — EP disclosed
WO-2022159986-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2022-07-28 — — WO disclosed
Send feedback